Lung cancer statistics, 2023
Despite decades of declining mortality rates, lung cancer remains the leading cause of
cancer death in the United States. This article examines lung cancer incidence, stage at …
cancer death in the United States. This article examines lung cancer incidence, stage at …
Colorectal cancer statistics, 2023
Colorectal cancer (CRC) is the second most common cause of cancer death in the United
States. Every 3 years, the American Cancer Society provides an update of CRC statistics …
States. Every 3 years, the American Cancer Society provides an update of CRC statistics …
Cancer screening in the United States during the second year of the COVID-19 pandemic
PURPOSE To examine whether cancer screening prevalence in the United States during
2021 has returned to prepandemic levels using nationally representative data. METHODS …
2021 has returned to prepandemic levels using nationally representative data. METHODS …
Annual Report to the Nation on the Status of Cancer, part 2: Early assessment of the COVID‐19 pandemic's impact on cancer diagnosis
S Negoita, HS Chen, PV Sanchez, RL Sherman… - Cancer, 2024 - Wiley Online Library
Background With access to cancer care services limited because of coronavirus disease
2019 control measures, cancer diagnosis and treatment have been delayed. The authors …
2019 control measures, cancer diagnosis and treatment have been delayed. The authors …
Rates of routine cancer screening and diagnosis before vs after the COVID-19 pandemic
AH Oakes, K Boyce, C Patton, S Jain - JAMA oncology, 2023 - jamanetwork.com
Methods| This cross-sectional study used the Trilliant Health all-payer claims and
encounters database, which includes inpatient, outpatient, and prescription drug claims from …
encounters database, which includes inpatient, outpatient, and prescription drug claims from …
Updated review of major cancer risk factors and screening test use in the United States, with a focus on changes during the COVID-19 pandemic
We present national and state representative prevalence estimates of modifiable cancer risk
factors, preventive behaviors and services, and screening, with a focus on changes during …
factors, preventive behaviors and services, and screening, with a focus on changes during …
Breast and lung cancer screening among medicare enrollees during the COVID-19 pandemic
C Doan, S Li, JS Goodwin - JAMA network open, 2023 - jamanetwork.com
Importance Several studies reported sharp decreases in screening mammography for breast
cancer and low-dose computed tomographic screening for lung cancer in the early months …
cancer and low-dose computed tomographic screening for lung cancer in the early months …
Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment
Background The emergence of COVID-19 disrupted health care, with consequences for
cancer diagnoses and outcomes, especially for early stage diagnoses, which generally have …
cancer diagnoses and outcomes, especially for early stage diagnoses, which generally have …
Colorectal cancer stage at diagnosis before vs during the COVID-19 pandemic in Italy
Importance Delays in screening programs and the reluctance of patients to seek medical
attention because of the outbreak of SARS-CoV-2 could be associated with the risk of more …
attention because of the outbreak of SARS-CoV-2 could be associated with the risk of more …
[HTML][HTML] Changes in the Number of Gastrointestinal Cancers and Stage at Diagnosis with COVID-19 Pandemic in Japan: A Multicenter Cohort Study
K Kuzuu, N Misawa, K Ashikari, S Tamura, S Kato… - Cancers, 2023 - mdpi.com
Simple Summary The number of gastrointestinal cancer patients declined during the COVID-
19 pandemic. In Japan, the number of early-stage gastric and colorectal cancer patients …
19 pandemic. In Japan, the number of early-stage gastric and colorectal cancer patients …